27 U.S. Cities Where Stocks Yield 26% a Year

From Investing Daily | Ad

What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.

Get in on the action here.

CCCC Insider Trading (C4 Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 21.04%

Insider Buying (Last 12 Months): $84,000.00

Insider Selling (Last 12 Months): $8,758,321.82

C4 Therapeutics Insider Trading History Chart

C4 Therapeutics Share Price & Price History

^$7.15

▲ +0.41 (6.08%)

As of 05/13/2022 07:55 PM ET

Days: 30 | 90 | 365

The Last Great Value Stock

From Oxford Club | Ad

Last year it was more profitable than Disney, Square or even Tesla. But it's just under $2 per share.

This company's unusual business model has created a rare situation where it is both cheap and highly profitable, but it may not be $2 for long.

Check out the free presentation by clicking here.

>>>

C4 Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/12/2022	Andrew Hirsch	CEO	Buy	10,000	$8.40	$84,000.00	10,000
12/17/2021	Malcolm Salter	Director	Sell	755	$30.25	$22,838.75
11/19/2021	Malcolm Salter	Director	Sell	755	$40.11	$30,283.05
10/15/2021	Malcolm Salter	Director	Sell	755	$44.94	$33,929.70
10/1/2021	Adam Crystal	Insider	Sell	15,000	$45.43	$681,450.00
9/27/2021	Elena Prokupets	Director	Sell	1,850	$50.04	$92,574.00
9/23/2021	Elena Prokupets	Director	Sell	19,180	$50.41	$966,863.80
9/21/2021	Elena Prokupets	Director	Sell	10,321	$50.14	$517,494.94
9/17/2021	Elena Prokupets	Director	Sell	10,840	$50.05	$542,542.00
9/15/2021	Elena Prokupets	Director	Sell	54,193	$48.82	$2,645,702.26
9/13/2021	Elena Prokupets	Director	Sell	6,660	$50.07	$333,466.20
9/10/2021	Elena Prokupets	Director	Sell	2,550	$50.00	$127,500.00
8/20/2021	Malcolm Salter	Director	Sell	755	$40.73	$30,751.15	13,672
8/2/2021	Elena Prokupets	Director	Sell	4,257	$45.01	$191,607.57
8/2/2021	Stewart L. Fisher	Insider	Sell	18,104	$45.00	$814,680.00
7/29/2021	Elena Prokupets	Director	Sell	11,336	$45.00	$510,120.00
7/29/2021	Jolie Siegel	Insider	Sell	12,500	$45.00	$562,500.00
7/16/2021	Malcolm Salter	Director	Sell	755	$37.37	$28,214.35	14,427
7/1/2021	Adam Crystal	Insider	Sell	15,000	$37.98	$569,700.00	15,000
6/18/2021	Malcolm Salter	Director	Sell	755	$37.19	$28,078.45	14,843
5/21/2021	Malcolm Salter	Director	Sell	755	$37.12	$28,025.60	15,598
4/5/2021	Adam Crystal	Insider	Sell	15,000	$37.77	$566,550.00	15,000
10/6/2020	Marc A Cohen	Director	Buy	5,030	$19.00	$95,570.00
10/6/2020	William Mckee	CFO	Buy	5,263	$19.00	$99,997.00

This Stock Under $2 Could Go to $20 (And STILL Be a SCREAMING BUY)

From Oxford Club | Ad

Analysts predict earnings will soar more than 320% this year...Possibly as much as 500%!

Discover the last opportunity that could still rocket skyward in THIS market.

Click Here to Discover Details on the Shocking Less Than $2 Stock.

>>>

SEC Filings (Institutional Ownership Changes) for C4 Therapeutics (NASDAQ:CCCC)

73.60% of C4 Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

C4 Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/13/2022	Bellevue Group AG	54,500	$1.32M	0.0%	+15.5%	0.112%
5/13/2022	Northern Trust Corp	349,262	$8.47M	0.0%	-3.4%	0.716%
5/13/2022	Charles Schwab Investment Management Inc.	273,137	$6.63M	0.0%	+3.2%	0.560%
5/13/2022	Lazard Asset Management LLC	3,834	$93K	0.0%	N/A	0.008%
5/13/2022	Mariner LLC	125,030	$3.03M	0.0%	N/A	0.256%
5/13/2022	Wasatch Advisors Inc.	1,538,525	$37.33M	0.2%	+18.8%	3.153%
5/13/2022	Vanguard Group Inc.	2,022,142	$49.06M	0.0%	+0.3%	4.144%
5/12/2022	BlackRock Inc.	3,139,990	$76.18M	0.0%	-7.8%	6.435%
5/12/2022	Rhumbline Advisers	40,699	$0.99M	0.0%	+6.3%	0.083%
5/12/2022	Metropolitan Life Insurance Co NY	2,583	$63K	0.0%	-75.1%	0.005%
5/12/2022	MetLife Investment Management LLC	21,112	$0.51M	0.0%	+58.5%	0.043%
5/12/2022	AlphaCrest Capital Management LLC	42,027	$1.02M	0.1%	N/A	0.086%
5/12/2022	Citigroup Inc.	23,818	$0.58M	0.0%	-71.1%	0.049%
5/11/2022	Bank of New York Mellon Corp	127,072	$3.08M	0.0%	+1.3%	0.260%
5/11/2022	JPMorgan Chase & Co.	69,420	$1.68M	0.0%	+141.7%	0.142%
5/10/2022	ProShare Advisors LLC	12,296	$0.30M	0.0%	-19.6%	0.025%
5/10/2022	Fox Run Management L.L.C.	8,926	$0.22M	0.1%	N/A	0.018%
5/9/2022	Northwestern Mutual Wealth Management Co.	14,540	$0.35M	0.0%	+126.5%	0.030%
5/9/2022	Swiss National Bank	28,800	$0.70M	0.0%	+7.9%	0.059%
5/9/2022	M&T Bank Corp	17,348	$0.42M	0.0%	+134.3%	0.036%
5/6/2022	Tortoise Investment Management LLC	1,842	$45K	0.0%	N/A	0.004%
4/29/2022	Cypress Point Wealth Management LLC	118,573	$2.88M	2.9%	N/A	0.243%
4/28/2022	Harbor Capital Advisors Inc.	21,868	$0.53M	0.3%	-21.3%	0.045%
4/28/2022	DekaBank Deutsche Girozentrale	19,800	$0.48M	0.0%	+10.0%	0.041%
3/3/2022	Walleye Capital LLC	81,720	$2.63M	0.1%	N/A	0.168%
2/23/2022	BlackRock Inc.	3,405,982	$109.67M	0.0%	+7.9%	7.004%
2/19/2022	Wells Fargo & Company MN	31,228	$1.01M	0.0%	+10.1%	0.064%
2/16/2022	Deutsche Bank AG	56,040	$1.81M	0.0%	+131.7%	0.115%
2/16/2022	California State Teachers Retirement System	31,191	$1M	0.0%	+4.9%	0.064%
2/16/2022	Parametric Portfolio Associates LLC	27,615	$0.89M	0.0%	+2.5%	0.057%
2/16/2022	Wasatch Advisors Inc.	1,295,462	$41.71M	0.2%	-3.5%	2.664%
2/15/2022	Schonfeld Strategic Advisors LLC	45,112	$1.45M	0.0%	-27.5%	0.093%
2/15/2022	Shay Capital LLC	15,000	$0.48M	0.1%	-60.0%	0.031%
2/15/2022	Laurion Capital Management LP	581,028	$18.71M	0.2%	-12.3%	1.195%
2/15/2022	Legal & General Group Plc	7,615	$0.25M	0.0%	+7.4%	0.016%
2/15/2022	Millennium Management LLC	753,391	$24.26M	0.0%	+162.0%	1.549%
2/15/2022	Cubist Systematic Strategies LLC	33,997	$1.10M	0.0%	-8.9%	0.070%
2/15/2022	Adage Capital Partners GP L.L.C.	996,477	$32.09M	0.1%	+22.8%	2.049%
2/14/2022	D. E. Shaw & Co. Inc.	25,735	$0.83M	0.0%	+160.4%	0.053%
2/14/2022	Virtus ETF Advisers LLC	5,589	$0.18M	0.1%	+10.8%	0.011%
2/14/2022	Squarepoint Ops LLC	13,001	$0.42M	0.0%	N/A	0.027%
2/14/2022	Perceptive Advisors LLC	2,208,913	$71.13M	1.1%	-2.2%	4.543%
2/14/2022	Point72 Hong Kong Ltd	2,011	$65K	0.0%	+49.7%	0.004%
2/14/2022	Nextech Invest AG	375,857	$12.10M	2.8%	N/A	0.773%
2/14/2022	Alliancebernstein L.P.	102,567	$3.30M	0.0%	+26.3%	0.211%
2/14/2022	Credit Suisse AG	9,288	$0.30M	0.0%	+8.9%	0.019%
2/14/2022	State Street Corp	1,589,753	$51.19M	0.0%	-4.2%	3.269%
2/14/2022	Goldman Sachs Group Inc.	224,848	$7.24M	0.0%	-14.8%	0.462%
2/14/2022	Nuveen Asset Management LLC	263,402	$7.47M	0.0%	-14.3%	0.542%
2/14/2022	Soleus Capital Management L.P.	561,122	$18.07M	1.8%	-25.2%	1.154%
2/14/2022	Clough Capital Partners L P	255,681	$8.23M	0.6%	-26.4%	0.526%
2/14/2022	Invesco Ltd.	464,202	$14.95M	0.0%	-1.3%	0.955%
2/11/2022	Geode Capital Management LLC	686,176	$22.09M	0.0%	+3.0%	1.411%
2/11/2022	Renaissance Technologies LLC	31,300	$1.01M	0.0%	N/A	0.064%
2/11/2022	Charles Schwab Investment Management Inc.	264,651	$8.52M	0.0%	+1.6%	0.544%
2/11/2022	Ensign Peak Advisors Inc	28,353	$0.91M	0.0%	+9.9%	0.058%
2/11/2022	Bank of Montreal Can	54,100	$1.78M	0.0%	N/A	0.111%
2/10/2022	JPMorgan Chase & Co.	28,722	$0.93M	0.0%	-47.6%	0.059%
2/10/2022	Pictet Asset Management SA	1,060,628	$34.15M	0.0%	-3.4%	2.181%
2/10/2022	Rafferty Asset Management LLC	92,007	$2.96M	0.0%	+55.8%	0.189%
2/10/2022	Citigroup Inc.	82,476	$2.66M	0.0%	+23.5%	0.170%
2/10/2022	TD Asset Management Inc.	106,353	$3.43M	0.0%	+6.6%	0.219%
2/9/2022	Principal Financial Group Inc.	6,570	$0.21M	0.0%	-18.9%	0.014%
2/8/2022	Jennison Associates LLC	27,001	$0.87M	0.0%	-94.4%	0.056%
2/8/2022	Bank of America Corp DE	101,673	$3.27M	0.0%	+371.8%	0.209%
2/8/2022	Swiss National Bank	26,700	$0.86M	0.0%	+12.2%	0.055%
2/8/2022	ProShare Advisors LLC	15,285	$0.49M	0.0%	+208.7%	0.031%
2/8/2022	Northern Trust Corp	361,696	$11.65M	0.0%	-0.6%	0.744%
2/7/2022	Victory Capital Management Inc.	16,530	$0.53M	0.0%	+63.0%	0.034%
2/7/2022	SG Americas Securities LLC	7,149	$0.23M	0.0%	-39.1%	0.015%
2/7/2022	M&T Bank Corp	7,404	$0.24M	0.0%	+24.3%	0.015%
2/4/2022	Harbor Capital Advisors Inc.	27,791	$0.90M	0.3%	N/A	0.057%
2/3/2022	Northwestern Mutual Wealth Management Co.	6,420	$0.21M	0.0%	-45.0%	0.013%
2/3/2022	Nisa Investment Advisors LLC	1,620	$40K	0.0%	+134.8%	0.003%
2/2/2022	New York State Common Retirement Fund	28,523	$0.92M	0.0%	+14.3%	0.059%
2/2/2022	DekaBank Deutsche Girozentrale	18,000	$0.59M	0.0%	N/A	0.037%
2/1/2022	Zurcher Kantonalbank Zurich Cantonalbank	3,421	$0.11M	0.0%	N/A	0.007%
1/28/2022	Allspring Global Investments Holdings LLC	15,667	$0.50M	0.0%	N/A	0.032%
1/27/2022	Regentatlantic Capital LLC	10,952	$0.35M	0.0%	-12.9%	0.023%
11/19/2021	American International Group Inc.	21,146	$0.95M	0.0%	+9.6%	0.043%
11/18/2021	Bank of New York Mellon Corp	112,598	$5.03M	0.0%	+33.2%	0.232%
11/17/2021	ArrowMark Colorado Holdings LLC	1,514,620	$67.67M	0.5%	+8.5%	3.115%
11/16/2021	Schonfeld Strategic Advisors LLC	62,253	$2.78M	0.0%	N/A	0.128%
11/16/2021	Janus Henderson Group PLC	1,048,888	$46.87M	0.0%	-7.4%	2.157%
11/16/2021	Migdal Insurance & Financial Holdings Ltd.	1,194	$53K	0.0%	N/A	0.002%
11/16/2021	Two Sigma Investments LP	21,073	$0.94M	0.0%	+92.0%	0.043%
11/16/2021	UBS Group AG	417,353	$18.65M	0.0%	+4.0%	0.861%
11/16/2021	Voloridge Investment Management LLC	105,314	$4.71M	0.0%	+9.4%	0.217%
11/16/2021	Laurion Capital Management LP	662,463	$29.60M	0.1%	-18.8%	1.367%
11/16/2021	Millennium Management LLC	287,573	$12.85M	0.0%	-25.2%	0.593%
11/16/2021	Clough Capital Partners L P	347,500	$15.53M	0.9%	+176.7%	0.717%
11/15/2021	Point72 Asset Management L.P.	200,000	$8.94M	0.0%	+20.8%	0.413%
11/15/2021	Cubist Systematic Strategies LLC	37,300	$1.67M	0.0%	+283.2%	0.077%
11/15/2021	Man Group plc	6,423	$0.29M	0.0%	+18.4%	0.013%
11/15/2021	California State Teachers Retirement System	29,732	$1.33M	0.0%	-37.4%	0.061%
11/15/2021	RTW Investments LP	2,494,965	$111.48M	1.7%	+16.1%	5.149%
11/15/2021	Pura Vida Investments LLC	20,000	$0.89M	0.0%	N/A	0.041%
11/15/2021	Royal Bank of Canada	7,625	$0.34M	0.0%	+47.3%	0.016%
11/15/2021	Morgan Stanley	290,096	$12.96M	0.0%	+5.0%	0.599%
11/15/2021	Sphera Funds Management LTD.	381,774	$17.06M	1.4%	-26.4%	0.788%

Data available starting January 2016

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable BiDAC degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; CFT1946, an orally bioavailable BiDAC degrader targeting V600X mutant BRAF to treat melanoma, non-small cell lung cancer (NSCLC), colorectal cancer, and other solid malignancies; CFT8919, an orally bioavailable, allosteric, and mutant-selective BiDAC degrader of epidermal growth factor receptor, or EGFR, with an L858R mutation in NSCLC; and earlier stage programs comprising RET degraders for the treatment of various cancers. C4 Therapeutics, Inc. has strategic collaborations with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; Biogen MA, Inc.; and Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $7.15

$6.95

$7.54

50 Day Range

MA: $15.90

$6.43

$26.46

52 Week Range

Now: $7.15

$6.26

$51.21

Volume

1,030,000 shs

Average Volume

835,477 shs

Market Capitalization

$348.90 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.77

Who are the company insiders with the largest holdings of C4 Therapeutics?: C4 Therapeutics' top insider shareholders include:
Malcolm Salter (Director)
Adam Crystal (Insider)
Andrew Hirsch (CEO)
Elena Prokupets (Director)
Jolie Siegel (Insider)
Marc A Cohen (Director)
Stewart Fisher (Insider)
William Mckee (CFO)
Learn More about top insider investors at C4 Therapeutics.
Who are the major institutional investors of C4 Therapeutics?: C4 Therapeutics' top institutional investors include:
BlackRock Inc. — 6.43%
Vanguard Group Inc. — 4.14%
Wasatch Advisors Inc. — 3.15%
Northern Trust Corp — 0.72%
Charles Schwab Investment Management Inc. — 0.56%
Bank of New York Mellon Corp — 0.26%
Learn More about top institutional investors of C4 Therapeutics stock.
Which major investors are selling C4 Therapeutics stock?: In the last quarter, CCCC stock was sold by these institutional investors:
BlackRock Inc.
Citigroup Inc.
Northern Trust Corp
Metropolitan Life Insurance Co NY
Harbor Capital Advisors Inc.
ProShare Advisors LLC
Within the last year, company insiders that have sold C4 Therapeutics company stock include:
Malcolm Salter (Director)
Adam Crystal (Insider)
Andrew Hirsch (CEO)
Elena Prokupets (Director)
Jolie Siegel (Insider)
Learn More investors selling C4 Therapeutics stock.
Which major investors are buying C4 Therapeutics stock?: During the last quarter, CCCC stock was purchased by institutional investors including:
Wasatch Advisors Inc.
Mariner LLC
Cypress Point Wealth Management LLC
AlphaCrest Capital Management LLC
JPMorgan Chase & Co.
M&T Bank Corp
Fox Run Management L.L.C.
Charles Schwab Investment Management Inc.
In the previous year, these company insiders have bought C4 Therapeutics stock:
Malcolm Salter (Director)
Adam Crystal (Insider)
Andrew Hirsch (CEO)
Learn More investors buying C4 Therapeutics stock.

New Wave of Bankruptcies Could Affect Millions

From Investor Place Media | Ad

People have watched the stock market crash and level off. They've watched as real estate, oil and food prices soar.

And they mistakenly think the worst has passed.... Many Americans STILL aren't taking the steps necessary to prepare themselves.

If you own a 401k or IRA, you must see this urgent message.

>>>